SceneRay Medical was selected into the third batch of potential landmark enterprises in the biopharmaceutical industry!

The biopharmaceutical industry is Suzhou's top industry, a sector that the city is actively developing. Suzhou has always attached great importance to the development and construction of innovative clusters within the biopharmaceutical industry.

Recently, the third batch of Suzhou's biopharmaceutical industry potential landmark enterprises was announced, with a total of 17 companies selected, including Jingyu Medical.

List of the Third Batch of Biopharmaceutical Industry Potential Landmark Enterprises

(Listed in no particular order)

SceneRay Medical's founder, Ning Yihua, is the Vice Chairman of the Third Branch of the China Democratic League Suzhou Industrial Park and the founding president of the Dushu Alliance, China's first independent innovation medical device alliance.

As an outstanding representative of the China Democratic League, Ning Yihua recently accepted congratulations from the Suzhou China Democratic League. He said, "The explosive growth of the medical industry is worth anticipating. In recent years, Suzhou's biomedical industry has maintained a positive momentum. Jingyu Medical will continue to seize development opportunities, grow stronger, and continuously inject strength into China's medical industry!"

In the cutting-edge and promising field of brain science, Jingyu Medical has consistently pursued independent innovation since its inception, developing new technologies and products with fully independent intellectual property rights. From 2022 to 2023, the company was listed on the Hurun Report's list of potential global unicorns for two consecutive years, and it is the only Chinese medical company focused on brain science.

Leveraging innovation as a key, Jingyu Medical has opened the door to high-quality development. It has not only explored a differentiated development path in Parkinson's disease treatment but has also achieved groundbreaking results in the treatment of mental illnesses. This multi-dimensional blueprint for Jingyu's development is slowly unfolding...